首页 | 本学科首页   官方微博 | 高级检索  
     

伊马替尼体外诱导Kasumi-1细胞增殖、分化与凋亡作用
引用本文:陈森,王莉红,饶青,王敏,王建祥. 伊马替尼体外诱导Kasumi-1细胞增殖、分化与凋亡作用[J]. 中华血液学杂志, 2005, 26(8): 449-452
作者姓名:陈森  王莉红  饶青  王敏  王建祥
作者单位:300020,天津,中国医学科学院、中国协和医科大学血液学研究所、血液病医院;实验血液学国家重点实验室
基金项目:国家自然科学基金资助项目(30470750)
摘    要:目的探讨酪氨酸激酶抑制剂伊马替尼诱导携带c-k it突变的细胞增殖、分化与凋亡的作用。方法应用MTT比色法观察伊马替尼对Kasum i-1细胞的生长抑制作用,流式细胞术分析细胞周期、c-k it抗原和髓系分化抗原CD11b、CD13和CD15的表达,AnnexinⅤ标记和DNA凝胶电泳分析细胞凋亡,应用W estern b lot方法分析Kasum i-1细胞c-k it蛋白酪氨酸磷酸化水平。结果伊马替尼呈时间和剂量依赖性抑制Kasum i-1细胞生长,72 h半数抑制浓度(IC50)为4.45μmol/L;伊马替尼5.00μmol/L使Kasum i-1细胞阻滞于G0/G1期,S期细胞减少;髓系分化抗原CD11b、CD13和CD15表达增加;作用24 h,早期凋亡细胞比例由9.04%升至86.84%(P<0.05),培养第5天出现明显DNA梯形条带;作用72 h,Kasum i-1细胞中c-k it蛋白酪氨酸磷酸化水平下降。结论酪氨酸激酶抑制剂伊马替尼能够抑制携带c-k it突变的细胞的生长,诱导细胞分化和凋亡。

关 键 词:伊马替尼 Kasumi-1 细胞增殖 分化 细胞凋亡 酪氨酸磷酸化
修稿时间:2004-11-02

Effect of tyrosine kinase inhibitor Imatinib mesylate on proliferation,differentiation and apoptosis of Kasumi-1 leukemia cell line
CHEN Sen,WANG Li-hong,RAO Qing,WANG Min,WANG Jian-xiang. Effect of tyrosine kinase inhibitor Imatinib mesylate on proliferation,differentiation and apoptosis of Kasumi-1 leukemia cell line[J]. Chinese Journal of Hematology, 2005, 26(8): 449-452
Authors:CHEN Sen  WANG Li-hong  RAO Qing  WANG Min  WANG Jian-xiang
Affiliation:State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, CAMS and PUMC, Tianjin, China.
Abstract:OBJECTIVE: To explore the effect of Imatinib mesylate on proliferation, differentiation and apoptosis of leukemic Kasumi-1 cells bearing c-kit mutation. METHODS: Kasumi-1 cells were treated with Imatinib at different concentrations in culture. Cell proliferation was assayed by MTT assay, expressions of c-kit antigen, surface myeloid antigen and cell cycle by flow cytometry, cell apoptosis by annexin V staining and agarose gel electrophoresis. Western blot was used to analyze the level of c-kit protein tyrosine phosphorylation. RESULTS: Imatinib treatment caused a time- and dose-dependent inhibition of the cell proliferation, with a 72 h IC50 of 4.45 micromol/L. Imatinib treatment induced a decrease in the mean fluorescence value of c-kit antigen, a progressive decline in S-phase cell fraction and an increase in G0/G1 cells. Treatment with 5.00 micromol/L of imatinib for 72 h induced an increase in expression of myeloid surface protein CD11, CD13 and CD15, and for 24 h induced an increase in early apoptosis cells [from 9.04% to 86.84% (P < 0.05)]. The apoptosis ladder was observed on agarose gel electrophoresis on 5-day treatment. Tyrosine phosphorylation level of c-kit protein was decreased by Imatinib treatment. CONCLUSION: Tyrosine kinase inhibitor Imatinib mesylate treatment could inhibit proliferation of Kasumi-1 cells which bear a c-kit mutation, induce differentiation, apoptosis and G0/G1 cells accumulation.
Keywords:Cell line   Kasumi-1  Gene   c-kit  Imatinib  Cell apoptosis  Tyrosine phosphorylation
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号